Editorial
doi: 10.2450/2012.0182-11.
Epub 2012 Feb 13.
Prophylaxis for adults with haemophilia: towards a personalised approach?
- PMID: 22337279
- PMCID: PMC3320771
- DOI: 10.2450/2012.0182-11
Item in Clipboard
Editorial
Prophylaxis for adults with haemophilia: towards a personalised approach?
Blood Transfus.
2012 Apr.
No abstract available
Similar articles
-
Prophylaxis in the haemophilia population-optimizing therapy.Haemophilia. 2007 May;13(3):227-32. doi: 10.1111/j.1365-2516.2007.01457.x. Haemophilia. 2007. PMID: 17498070 No abstract available.
-
Rationale for individualizing haemophilia care.Blood Coagul Fibrinolysis. 2015 Dec;26(8):849-57. doi: 10.1097/MBC.0000000000000225. Blood Coagul Fibrinolysis. 2015. PMID: 25396764 Review.
-
Outcome measures in haemophilia: more than just factor levels.Haemophilia. 2004 Mar;10 Suppl 1:2-8. doi: 10.1111/j.1355-0691.2004.00873.x. Haemophilia. 2004. PMID: 14987243 Review. No abstract available.
-
Adherence to Prophylaxis in Adolescents and Young Adults with Severe Haemophilia: A Quantitative Study with Patients.PLoS One. 2017 Jan 19;12(1):e0169880. doi: 10.1371/journal.pone.0169880. eCollection 2017. PLoS One. 2017. PMID: 28103266 Free PMC article.
-
Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25years and its potential association with bleeding episodes.Thromb Res. 2016 Jul;143:22-7. doi: 10.1016/j.thromres.2016.04.015. Epub 2016 Apr 25. Thromb Res. 2016. PMID: 27172834
Cited by
-
Understanding patient preferences and willingness to pay for hemophilia therapies.Patient Prefer Adherence. 2015 Nov 11;9:1623-30. doi: 10.2147/PPA.S92985. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26635471 Free PMC article.
-
Intermediate Dose Prophylaxis in Adults with Haemophilia: A Clinical Audit from a Resource Limited Setting.Indian J Hematol Blood Transfus. 2020 Apr;36(2):374-376. doi: 10.1007/s12288-019-01189-4. Epub 2019 Sep 18. Indian J Hematol Blood Transfus. 2020. PMID: 32425392 Free PMC article.
-
Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method.Biologics. 2014 Apr 5;8:115-27. doi: 10.2147/BTT.S53456. eCollection 2014. Biologics. 2014. PMID: 24741292 Free PMC article. Review.
-
Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatment.Biotechnol Biotechnol Equip. 2014 May 4;28(3):576-582. doi: 10.1080/13102818.2014.926687. Epub 2014 Aug 26. Biotechnol Biotechnol Equip. 2014. PMID: 26019545 Free PMC article.
-
Present and future challenges in the treatment of haemophilia: the patient's perspective.Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s82-5. doi: 10.2450/2013.013s. Blood Transfus. 2013. PMID: 24333318 Free PMC article. Review. No abstract available.
References
-
- Coppola A, Franchini M, Tagliaferri A. Prophylaxis in people with hemophilia. Thromb Haemost. 2009;101:674–81. - PubMed
-
- Blanchette VS. Prophylaxis in the haemophilia population. Haemophilia. 2010;16(Suppl 5):181–8. - PubMed
-
- Ljung R. Prophylactic therapy in haemophilia. Blood Rev. 2009;23:267–74. - PubMed
-
- Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357:535–44. - PubMed
-
- Gringeri A, Lundin B, von Mackensen S, et al. A randomized clinical trial of prophylaxis in children with haemophilia A (the ESPRIT study) J Thromb Haemost. 2011;9:700–10. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
